Dean Willis

Title: Dean Willis - Innovator in Pharmaceutical Control of Inflammation

Introduction

Dean Willis is a notable inventor based in Atherstone, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the control of inflammation. His innovative approach focuses on the enzyme heme-oxygenase (HO), which plays a crucial role in inflammatory processes.

Latest Patents

Dean Willis holds 1 patent for his work titled "Pharmaceutical control of inflammation." This patent outlines a method for controlling inflammation by regulating the level and activity of the enzyme heme-oxygenase. The invention describes how a HO inducer can serve as an anti-inflammatory agent, useful in treating chronic inflammatory diseases. Conversely, a HO inhibitor can promote inflammation and is beneficial for treating immunosuppressed conditions. Additionally, the patent discusses alternative methods for controlling heme-oxygenase activity through the regulation of nitric oxide levels, where elevated levels can lead to increased inflammation.

Career Highlights

Dean Willis is associated with William Harvey Research Limited, where he applies his expertise in pharmaceutical research. His work has been instrumental in advancing the understanding of inflammation and its treatment.

Collaborations

Throughout his career, Dean has collaborated with notable colleagues, including Adrian Richard Moore and Derek A Willoughby. These partnerships have contributed to the development of innovative solutions in the pharmaceutical industry.

Conclusion

Dean Willis is a pioneering inventor whose work in the pharmaceutical control of inflammation has the potential to impact the treatment of various inflammatory conditions. His contributions to the field are significant and reflect his dedication to advancing medical science.